Back to search results

Denosumab for Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Type 1 Diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Tiffany Grimes) · tdgrimes1@uabmc.edu · 205-996-4777
    Contact: Study coordinator (Julia Smith) · juliaparker@uabmc.edu · 205-224-7582
    Contact: Principal Investigator (Anath Shalev, MD)

  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Fouad Kandeel, MD, PhD) · Islets@coh.org · 866-444-7538
    Contact: Principal Investigator (Fouad Kandeel, MD, PhD)

  • Indiana University, Indianapolis, Indiana, United States

    Contact: Study coordinator (Hannah Lease) · hlease@iu.edu · 317-278-2538
    Contact: Principal Investigator (Carmella Evans-Molina, MD)
Study leads

  • Fouad Kandeel, MD, PhD

    Principal Investigator

    City of Hope Medical Center

  • Rupangi Vasavada, PhD

    Principal Investigator

    City of Hope Medical Center

View source on ClinicalTrials.gov(opens in a new tab)